Intermittent fasting tested to ease radiation side effects in cancer patients

NCT ID NCT05722288

First seen Jun 26, 2026 · Last updated Aug 14, 2026 · Updated 3 times

Summary

This phase II trial tests whether time-restricted eating (intermittent fasting) can reduce side effects from radiation or chemoradiation in people with prostate, cervical, or rectal cancers. About 49 participants will either follow a time-restricted eating plan or receive standard nutritional counseling during treatment. The study aims to see if this eating pattern is feasible and helps lower DNA damage in normal tissues, potentially improving how well patients tolerate therapy.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
time-restricted eating (intermittent fasting)
What this could lead to
If it works, this could offer a simple dietary strategy to reduce side effects from radiation therapy and potentially improve treatment outcomes for certain cancers.
What could go wrong
This is a small, early-phase trial with only 49 participants, so results may not apply broadly. The intervention may be difficult for some patients to follow, and it is not yet proven to reduce side effects or improve cancer control.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOCALIZED PROSTATE CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • City of Hope Medical Center

    Duarte, California, 91010, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.